| sodium channel, voltage-gated, type IV, beta | 
                DESLORATADINE | 
                Sodium Channel, Site 2 | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type IV, alpha | 
                DESLORATADINE | 
                Sodium Channel, Site 2 | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type III, alpha | 
                DESLORATADINE | 
                Sodium Channel, Site 2 | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type II, beta | 
                DESLORATADINE | 
                Sodium Channel, Site 2 | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type II, alpha 2 | 
                DESLORATADINE | 
                Sodium Channel, Site 2 | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type I, beta | 
                DESLORATADINE | 
                Sodium Channel, Site 2 | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type I, alpha | 
                DESLORATADINE | 
                Sodium Channel, Site 2 | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | 3-hydroxy-3-methylglutaryl-Coenzyme A reductase | 
                ZAFIRLUKAST | 
                HMG-CoA Reductase | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | 3-hydroxy-3-methylglutaryl-Coenzyme A reductase | 
                ZAFIRLUKAST | 
                HMG-CoA Reductase | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrom P450-2D6 monooxygenase | 
                KETOTIFEN | 
                CYP450-2D6 Inhibition | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) | 
                ALOSETRON | 
                CYP450-2C9 Inhibition | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | cytochrome P450, family 2, subfamily C, polypeptide 9 | 
                ALOSETRON | 
                CYP450-2C9 Inhibition | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) | 
                CHLORMADINONE ACETATE | 
                CYP450-2C9 Inhibition | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | cytochrome P450, family 2, subfamily C, polypeptide 9 | 
                CHLORMADINONE ACETATE | 
                CYP450-2C9 Inhibition | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | acetylcholinesterase (YT blood group) | 
                4-NONYLPHENOL | 
                Acetylcholinesterase | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase | 
                4-NONYLPHENOL | 
                Acetylcholinesterase | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | acetylcholinesterase | 
                4-NONYLPHENOL | 
                Acetylcholinesterase | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adenosine A2a receptor | 
                AMINOPHYLLINE | 
                Adenosine A2A | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 1d (Non-specific probe) | 
                METHYLERGONOVINE | 
                Adrenergic alpha1D | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 2b | 
                AMITRAZ | 
                Adrenergic alpha2B | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | 
                GRAMICIDIN | 
                Adrenergic, Norepinephrine Transporter | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | bradykinin receptor, beta 2 | 
                GRAMICIDIN | 
                Bradykinin B2 | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | bradykinin receptor B2 | 
                GRAMICIDIN | 
                Bradykinin B2 | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 2a | 
                MOXONIDINE | 
                Adrenergic alpha2A | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | A3 adenosine receptor | 
                DIGITONIN | 
                Adenosine A3 | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 2b | 
                O-ANISIDINE | 
                Adrenergic alpha2B | 
                67% | 
                2.508uM | 
                1.145uM | 
              
              
                View
               | 
              
            
          
            
                | neuropeptide Y receptor Y2 | 
                DIHYDROERGOCRISTINE MESYLATE | 
                Neuropeptide Y2 | 
                67% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Benzothiazepine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Benzothiazepine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Benzothiazepine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Benzothiazepine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Benzothiazepine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Benzothiazepine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 2b | 
                EPERISONE | 
                Adrenergic alpha2B | 
                71% | 
                3.034uM | 
                1.385uM | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, beta 1 | 
                BROMOCRIPTINE | 
                Adrenergic beta1 | 
                71% | 
                2.4uM | 
                1.386uM | 
              
              
                View
               | 
              
            
          
            
                | adrenergic, beta-1-, receptor | 
                BROMOCRIPTINE | 
                Adrenergic beta1 | 
                71% | 
                2.4uM | 
                1.386uM | 
              
              
                View
               | 
              
            
          
            
                | histamine receptor H 1 | 
                CITALOPRAM | 
                Histamine H1, Central | 
                71% | 
                3.194uM | 
                .371uM | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 2a | 
                VERAPAMIL | 
                Imidazoline I2, Central | 
                71% | 
                5.524uM | 
                3.683uM | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 2c (Non-specific probe) | 
                VERAPAMIL | 
                Imidazoline I2, Central | 
                71% | 
                5.524uM | 
                3.683uM | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 1b | 
                LYSERGOL | 
                Adrenergic alpha1B | 
                71% | 
                4.726uM | 
                2.616uM | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, nonvoltage-gated 1, delta | 
                PYRILAMINE | 
                Sodium Channel, Site 2 | 
                71% | 
                5.283uM | 
                4.819uM | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) | 
                PYRILAMINE | 
                Sodium Channel, Site 2 | 
                71% | 
                5.283uM | 
                4.819uM | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, nonvoltage-gated 1 alpha | 
                PYRILAMINE | 
                Sodium Channel, Site 2 | 
                71% | 
                5.283uM | 
                4.819uM | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type X, alpha | 
                PYRILAMINE | 
                Sodium Channel, Site 2 | 
                71% | 
                5.283uM | 
                4.819uM | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type IX, alpha | 
                PYRILAMINE | 
                Sodium Channel, Site 2 | 
                71% | 
                5.283uM | 
                4.819uM | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage gated, type VIII, alpha | 
                PYRILAMINE | 
                Sodium Channel, Site 2 | 
                71% | 
                5.283uM | 
                4.819uM | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type VII, alpha | 
                PYRILAMINE | 
                Sodium Channel, Site 2 | 
                71% | 
                5.283uM | 
                4.819uM | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) | 
                PYRILAMINE | 
                Sodium Channel, Site 2 | 
                71% | 
                5.283uM | 
                4.819uM | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type IV, beta | 
                PYRILAMINE | 
                Sodium Channel, Site 2 | 
                71% | 
                5.283uM | 
                4.819uM | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type IV, alpha | 
                PYRILAMINE | 
                Sodium Channel, Site 2 | 
                71% | 
                5.283uM | 
                4.819uM | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type III, alpha | 
                PYRILAMINE | 
                Sodium Channel, Site 2 | 
                71% | 
                5.283uM | 
                4.819uM | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type II, beta | 
                PYRILAMINE | 
                Sodium Channel, Site 2 | 
                71% | 
                5.283uM | 
                4.819uM | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type II, alpha 2 | 
                PYRILAMINE | 
                Sodium Channel, Site 2 | 
                71% | 
                5.283uM | 
                4.819uM | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type I, beta | 
                PYRILAMINE | 
                Sodium Channel, Site 2 | 
                71% | 
                5.283uM | 
                4.819uM | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type I, alpha | 
                PYRILAMINE | 
                Sodium Channel, Site 2 | 
                71% | 
                5.283uM | 
                4.819uM | 
              
              
                View
               | 
              
            
          
            
                | A3 adenosine receptor | 
                NELFINAVIR | 
                Adenosine A3 | 
                71% | 
                14.796uM | 
                8.363uM | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 1a | 
                TACRINE | 
                Adrenergic alpha1A | 
                71% | 
                2.749uM | 
                1.113uM | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, beta 2 | 
                ZIDOVUDINE | 
                Adrenergic beta2 | 
                12% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 
                PROCHLORPERAZINE | 
                Dopamine Transporter | 
                71% | 
                1.735uM | 
                1.379uM | 
              
              
                View
               | 
              
            
          
            
                | monoamine oxidase A | 
                PIOGLITAZONE | 
                Monoamine Oxidase MAOA | 
                71% | 
                35.069uM | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | monoamine oxidase A | 
                PIOGLITAZONE | 
                Monoamine Oxidase MAOA | 
                71% | 
                35.069uM | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | 5-hydroxytryptamine (serotonin) receptor 1A | 
                PIPAMAZINE | 
                Serotonin 5-HT1A | 
                71% | 
                1.782uM | 
                1.018uM | 
              
              
                View
               | 
              
            
          
            
                | Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) | 
                GW-1929 | 
                CYP450-2C9 Inhibition | 
                71% | 
                4uM | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | cytochrome P450, family 2, subfamily C, polypeptide 9 | 
                GW-1929 | 
                CYP450-2C9 Inhibition | 
                71% | 
                4uM | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | epidermal growth factor receptor | 
                GW-1929 | 
                Protein Tyrosine Kinase, EGF Receptor | 
                71% | 
                10.896uM | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | 
                MICONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                71% | 
                18.034uM | 
                16.03uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | 
                MICONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                71% | 
                18.034uM | 
                16.03uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | 
                MICONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                71% | 
                18.034uM | 
                16.03uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | 
                MICONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                71% | 
                18.034uM | 
                16.03uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | 
                MICONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                71% | 
                18.034uM | 
                16.03uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | 
                MICONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                71% | 
                18.034uM | 
                16.03uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | 
                MICONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                71% | 
                18.034uM | 
                16.03uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | 
                MICONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                71% | 
                18.034uM | 
                16.03uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | 
                MICONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                71% | 
                18.034uM | 
                16.03uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | 
                MICONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                71% | 
                18.034uM | 
                16.03uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | 
                MICONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                71% | 
                18.034uM | 
                16.03uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | 
                MICONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                71% | 
                18.034uM | 
                16.03uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | 
                MICONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                71% | 
                18.034uM | 
                16.03uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | 
                MICONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                71% | 
                18.034uM | 
                16.03uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | 
                MICONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                71% | 
                18.034uM | 
                16.03uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | 
                MICONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                71% | 
                18.034uM | 
                16.03uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | 
                MICONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                71% | 
                18.034uM | 
                16.03uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | 
                MICONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                71% | 
                18.034uM | 
                16.03uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | 
                MICONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                71% | 
                18.034uM | 
                16.03uM | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | 
                MICONAZOLE | 
                Calcium Channel Type L, Benzothiazepine | 
                71% | 
                18.034uM | 
                16.03uM | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, nonvoltage-gated 1 alpha | 
                AMOXAPINE | 
                Sodium Channel, Site 2 | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type X, alpha | 
                AMOXAPINE | 
                Sodium Channel, Site 2 | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type IX, alpha | 
                AMOXAPINE | 
                Sodium Channel, Site 2 | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage gated, type VIII, alpha | 
                AMOXAPINE | 
                Sodium Channel, Site 2 | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type VII, alpha | 
                AMOXAPINE | 
                Sodium Channel, Site 2 | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) | 
                AMOXAPINE | 
                Sodium Channel, Site 2 | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type IV, beta | 
                AMOXAPINE | 
                Sodium Channel, Site 2 | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type IV, alpha | 
                AMOXAPINE | 
                Sodium Channel, Site 2 | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type III, alpha | 
                AMOXAPINE | 
                Sodium Channel, Site 2 | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type II, beta | 
                AMOXAPINE | 
                Sodium Channel, Site 2 | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type II, alpha 2 | 
                AMOXAPINE | 
                Sodium Channel, Site 2 | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type I, beta | 
                AMOXAPINE | 
                Sodium Channel, Site 2 | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type I, alpha | 
                AMOXAPINE | 
                Sodium Channel, Site 2 | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type IV, beta | 
                AMOXAPINE | 
                Sodium Channel, Site 2 | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel associated protein 1 | 
                AMOXAPINE | 
                Sodium Channel, Site 2 | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2C | 
                CHLOROXYLENOL | 
                Serotonin 5-HT2C | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | nuclear receptor subfamily 3, group C, member 1 | 
                PREGNENOLONE-16ALPHA-CARBONITRILE | 
                Glucocorticoid | 
                69% | 
                13.957uM | 
                6.344uM | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 1b | 
                ERGONOVINE | 
                Adrenergic alpha1B | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | androgen receptor | 
                FLUOCINONIDE | 
                Testosterone | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | 
                FLUOXETINE | 
                Calcium Channel Type L, Dihydropyridine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | 
                FLUOXETINE | 
                Calcium Channel Type L, Dihydropyridine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | 
                FLUOXETINE | 
                Calcium Channel Type L, Dihydropyridine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | 
                FLUOXETINE | 
                Calcium Channel Type L, Dihydropyridine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | 
                FLUOXETINE | 
                Calcium Channel Type L, Dihydropyridine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | 
                FLUOXETINE | 
                Calcium Channel Type L, Dihydropyridine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | 
                FLUOXETINE | 
                Calcium Channel Type L, Dihydropyridine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | 
                FLUOXETINE | 
                Calcium Channel Type L, Dihydropyridine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | 
                FLUOXETINE | 
                Calcium Channel Type L, Dihydropyridine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | 
                FLUOXETINE | 
                Calcium Channel Type L, Dihydropyridine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | 
                FLUOXETINE | 
                Calcium Channel Type L, Dihydropyridine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | 
                FLUOXETINE | 
                Calcium Channel Type L, Dihydropyridine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | 
                FLUOXETINE | 
                Calcium Channel Type L, Dihydropyridine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | 
                FLUOXETINE | 
                Calcium Channel Type L, Dihydropyridine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | 
                FLUOXETINE | 
                Calcium Channel Type L, Dihydropyridine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | 
                FLUOXETINE | 
                Calcium Channel Type L, Dihydropyridine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | 
                FLUOXETINE | 
                Calcium Channel Type L, Dihydropyridine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | 
                FLUOXETINE | 
                Calcium Channel Type L, Dihydropyridine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | 
                FLUOXETINE | 
                Calcium Channel Type L, Dihydropyridine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | 
                FLUOXETINE | 
                Calcium Channel Type L, Dihydropyridine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | epidermal growth factor receptor | 
                FLUPHENAZINE | 
                Protein Tyrosine Kinase, EGF Receptor | 
                69% | 
                40.107uM | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | 
                DOXEPIN | 
                Calcium Channel Type L, Benzothiazepine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | 
                DOXEPIN | 
                Calcium Channel Type L, Benzothiazepine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | 
                DOXEPIN | 
                Calcium Channel Type L, Benzothiazepine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | 
                DOXEPIN | 
                Calcium Channel Type L, Benzothiazepine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | 
                DOXEPIN | 
                Calcium Channel Type L, Benzothiazepine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | 
                DOXEPIN | 
                Calcium Channel Type L, Benzothiazepine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | 
                DOXEPIN | 
                Calcium Channel Type L, Benzothiazepine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | 
                DOXEPIN | 
                Calcium Channel Type L, Benzothiazepine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | 
                DOXEPIN | 
                Calcium Channel Type L, Benzothiazepine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | 
                DOXEPIN | 
                Calcium Channel Type L, Benzothiazepine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | 
                DOXEPIN | 
                Calcium Channel Type L, Benzothiazepine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | 
                DOXEPIN | 
                Calcium Channel Type L, Benzothiazepine | 
                69% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Benzothiazepine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Benzothiazepine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Benzothiazepine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Benzothiazepine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Benzothiazepine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | 
                DEXTROMETHORPHAN | 
                Calcium Channel Type L, Benzothiazepine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 | 
                LABETALOL | 
                Serotonin Transporter | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, beta 2 | 
                BROMOCRIPTINE | 
                Adrenergic beta2 | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | prostaglandin-endoperoxide synthase 1 | 
                ISOEUGENOL | 
                Cyclooxygenase COX-1 | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | 
                ISOEUGENOL | 
                Cyclooxygenase COX-1 | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | chemokine (C-C motif) receptor 2 | 
                CISPLATIN | 
                Chemokine CCR2B | 
                66% | 
                18.142uM | 
                7.012uM | 
              
              
                View
               | 
              
            
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2A | 
                LOPERAMIDE | 
                Serotonin 5-HT2A | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | A3 adenosine receptor | 
                N,N'-DIPHENYL-P-PHENYLENEDIAMINE | 
                Adenosine A3 | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | 
                ITRACONAZOLE | 
                Calcium Channel Type L, Dihydropyridine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | 
                ITRACONAZOLE | 
                Calcium Channel Type L, Dihydropyridine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | 
                ITRACONAZOLE | 
                Calcium Channel Type L, Dihydropyridine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | 
                ITRACONAZOLE | 
                Calcium Channel Type L, Dihydropyridine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | 
                ITRACONAZOLE | 
                Calcium Channel Type L, Dihydropyridine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | 
                ITRACONAZOLE | 
                Calcium Channel Type L, Dihydropyridine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | 
                ITRACONAZOLE | 
                Calcium Channel Type L, Dihydropyridine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | 
                ITRACONAZOLE | 
                Calcium Channel Type L, Dihydropyridine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | 
                ITRACONAZOLE | 
                Calcium Channel Type L, Dihydropyridine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | 
                ITRACONAZOLE | 
                Calcium Channel Type L, Dihydropyridine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | 
                ITRACONAZOLE | 
                Calcium Channel Type L, Dihydropyridine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | 
                ITRACONAZOLE | 
                Calcium Channel Type L, Dihydropyridine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | 
                ITRACONAZOLE | 
                Calcium Channel Type L, Dihydropyridine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | 
                ITRACONAZOLE | 
                Calcium Channel Type L, Dihydropyridine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | 
                ITRACONAZOLE | 
                Calcium Channel Type L, Dihydropyridine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | 
                ITRACONAZOLE | 
                Calcium Channel Type L, Dihydropyridine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | 
                ITRACONAZOLE | 
                Calcium Channel Type L, Dihydropyridine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | 
                ITRACONAZOLE | 
                Calcium Channel Type L, Dihydropyridine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | 
                ITRACONAZOLE | 
                Calcium Channel Type L, Dihydropyridine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | 
                ITRACONAZOLE | 
                Calcium Channel Type L, Dihydropyridine | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Sigma-2 Receptor | 
                IRINOTECAN | 
                Sigma2 | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 2a | 
                IMIQUIMOD | 
                Adrenergic alpha2A | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | opioid receptor, kappa 1 | 
                RITONAVIR | 
                Opiate kappa | 
                66% | 
                13.655uM | 
                5.462uM | 
              
              
                View
               | 
              
            
          
            
                | Sigma-2 Receptor | 
                NORETHINDRONE ACETATE | 
                Sigma2 | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 
                OXICONAZOLE | 
                Protein Tyrosine Kinase, HER2 Receptor | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 
                OXICONAZOLE | 
                Protein Tyrosine Kinase, HER2 Receptor | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | mitogen activated protein kinase 14 | 
                EPALRESTAT | 
                Protein Serine/Threonine Kinase, p38alpha | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | mitogen-activated protein kinase 14 | 
                EPALRESTAT | 
                Protein Serine/Threonine Kinase, p38alpha | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | opioid receptor, sigma 1 | 
                ORPHENADRINE | 
                Sigma1 | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | arachidonate 15-lipoxygenase, second type | 
                RESVERATROL | 
                Lipoxygenase 15-LO | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | arachidonate 15-lipoxygenase | 
                RESVERATROL | 
                Lipoxygenase 15-LO | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | arachidonate 15-lipoxygenase | 
                RESVERATROL | 
                Lipoxygenase 15-LO | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Sigma-2 Receptor | 
                CETYLPYRIDINIUM BROMIDE | 
                Sigma2 | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | cholinergic receptor, muscarinic 5 | 
                RALOXIFENE | 
                Muscarinic M5 | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 
                DIPHENHYDRAMINE | 
                Dopamine Transporter | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | mu-opioid receptor MOR | 
                HALOPROGIN | 
                Opiate mu | 
                66% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | chemokine (C-C motif) receptor 5 | 
                DISULFIRAM | 
                Chemokine CCR5 | 
                66% | 
                23.661uM | 
                18.284uM | 
              
              
                View
               | 
              
            
          
            
                | ATPase, Na+/K+ transporting, beta 1 polypeptide | 
                MICONAZOLE | 
                ATPase, Na+/K+ | 
                66% | 
                19.279uM | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | ATPase, Na+/K+ transporting, beta 3 polypeptide | 
                MICONAZOLE | 
                ATPase, Na+/K+ | 
                66% | 
                19.279uM | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | ATPase, Na+/K+ transporting, beta 2 polypeptide | 
                MICONAZOLE | 
                ATPase, Na+/K+ | 
                66% | 
                19.279uM | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | histamine receptor H 2 | 
                DEXCHLORPHENIRAMINE | 
                Histamine H2 | 
                71% | 
                8.368uM | 
                8.228uM | 
              
              
                View
               | 
              
            
          
            
                | thromboxane A synthase 1 | 
                ERGOCORNINE | 
                Thromboxane Synthetase | 
                71% | 
                1.993uM | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) | 
                ERGOCORNINE | 
                Thromboxane Synthetase | 
                71% | 
                1.993uM | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2A | 
                SULCONAZOLE | 
                Serotonin 5-HT2A | 
                71% | 
                3.929uM | 
                1.122uM | 
              
              
                View
               | 
              
            
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2C | 
                SULCONAZOLE | 
                Serotonin 5-HT2C | 
                71% | 
                2.785uM | 
                1.459uM | 
              
              
                View
               | 
              
            
          
            
                | Cytochrom P450-2C19 monooxygenase | 
                MC 258714 | 
                CYP450-2C19 Inhibition | 
                71% | 
                3uM | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrom P450-2D6 monooxygenase | 
                CELECOXIB | 
                CYP450-2D6 Inhibition | 
                71% | 
                1uM | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2C | 
                U-78517F | 
                Serotonin 5-HT2C | 
                71% | 
                7.563uM | 
                3.962uM | 
              
              
                View
               | 
              
            
          
            
                | cholinergic receptor, muscarinic 2 | 
                AMOXAPINE | 
                Muscarinic M2 | 
                71% | 
                2.623uM | 
                .933uM | 
              
              
                View
               | 
              
            
          
            
                | endothelin receptor type A | 
                AMIODARONE | 
                Endothelin ETA | 
                71% | 
                26.288uM | 
                16.177uM | 
              
              
                View
               |